Valuation : AngioDynamics, Inc.

Market Cap 629M 541M 509M 464M 868M 59.84B 872M 6.03B 2.33B 30.5B 2.36B 2.31B 96.45B P/E 2027 *
-28.9x
P/E 2028 * -51.9x
Enterprise Value 629M 541M 509M 464M 868M 59.84B 872M 6.03B 2.33B 30.5B 2.36B 2.31B 96.45B EV / Sales 2027 *
1.86x
EV / Sales 2028 * 1.77x
Free-Float
86.06%
Yield 2027 *
-
Yield 2028 * -
1 day+0.66%
1 week-3.40%
Current month-5.02%
1 month-2.36%
3 months+28.42%
6 months+41.46%
Current year+19.31%
1 week 14.85
Extreme 14.85
15.83
1 month 14.85
Extreme 14.85
16.29
Current year 9.39
Extreme 9.39
16.29
1 year 9.39
Extreme 9.39
16.29
3 years 5.26
Extreme 5.26
16.29
5 years 5.26
Extreme 5.26
32
10 years 5.26
Extreme 5.26
32
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2016
Director of Finance/CFO 51 23/10/2019
Chief Tech/Sci/R&D Officer - 01/01/2017
Director TitleAgeSince
Chairman 65 29/04/2014
Director/Board Member 67 29/01/2007
Director/Board Member 62 01/04/2016
Date Insider Type Main position Quantity % Market Cap. Importance
30/07/26 Sell

General Counsel

-23,370 0.0565%
22/07/26 Exercice

Executive/Senior Manager

40,889 0.0990%
22/07/26 Exercice

General Counsel

27,417 0.0664%
Change 5-day change 1-year change 3-year change Capi.($)
+0.66%-3.40%+40.55%+115.47% 629M
-0.27%-3.40%-20.40%+4.47% 183B
-0.54%-0.16%-1.18%+14.92% 118B
-0.42%-2.31%+8.55%+81.95% 61.96B
-0.49%-6.75%+11.83%+44.52% 50.6B
+0.98%-3.91%-6.15%-32.60% 48.78B
-0.77%-6.94%+7.54%-19.62% 31.9B
-1.84%-3.02% - - 30.44B
-0.24%-0.50%+33.10%-14.30% 23.77B
-2.51%-10.87%-14.66%+6.30% 22.26B
Average -0.37%-2.86%+6.57%+22.35% 57.11B
Weighted average by Cap. +0.10%-1.89%-4.27%+13.99%

Financials

2027 *2028 *
Net sales 337M 290M 273M 249M 466M 32.09B 467M 3.23B 1.25B 16.35B 1.27B 1.24B 51.72B 355M 305M 288M 262M 490M 33.79B 492M 3.4B 1.32B 17.22B 1.33B 1.3B 54.45B
Net income -22.3M -19.16M -18.05M -16.46M -30.78M -2.12B -30.89M -214M -82.6M -1.08B -83.71M -81.9M -3.42B -12.67M -10.88M -10.25M -9.35M -17.48M -1.2B -17.55M -121M -46.92M -614M -47.55M -46.52M -1.94B
Net Debt - -
Logo AngioDynamics, Inc.
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. The Med Tech segment is comprised of its technology portfolio including Auryon, the thrombus management platform and NanoKnife. The Med Device segment includes its Core, Venous, Ports and other Oncology products. Its product types are Ablation, Catheters, Medical Balloons, and Ports. The Catheter products include Angiographic Catheters, Uni-Fuse Infusion Catheter and Drainage Catheters.
Employees
632
Date Price Change Volume
09/09/26 $15.32 +0.66% 328,774
08/09/26 $15.22 +0.13% 432,090
04/09/26 $15.20 -1.75% 527,438
03/09/26 $15.47 -0.96% 438,279
02/09/26 $15.62 -1.51% 311,414
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
15.32USD
Average target price
20.00USD
Spread / Average Target
+30.55%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ANGO Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!